Duration of cisplatin excretion in breast milk
Karen E Hays1, Rachel J Ryu, Elizabeth M Swisher
11Department of Pharmacy, University of Washington, Seattle, WA, USA.
Abstract:
Cisplatin, a platinum-based chemotherapy agent, is commonly used in treating cancers that may affect women of childbearing age, including cervical cancer, triple-negative breast cancer, and pediatric tumors in adolescents. The authors found that platinum was undetectable in breast milk at 66 hours and beyond following a 70-mg dose of intravenous cisplatin. Relative infant dose of platinum was calculated to be between 0.29% and 0.40% of the maternal dose corrected for body weight. This case demonstrates minimal exposure to platinum via breast milk, following a single 70-mg intravenous dose of cisplatin.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Excretion: Pulmonary and Glandular Routes
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The process...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Excretion: Miscellaneous Routes

